These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7472282)

  • 1. Effects of an inhibitor of hepatic drug metabolism, 2-diethylaminoethyl-2,2-diphenylvalerate HCl (SKF 525-A), on thyroxine metabolism in the rat.
    Nakamura Y; Bellamy G; Green WL
    Endocrinology; 1981 Apr; 108(4):1519-36. PubMed ID: 7472282
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of cimetidine and diethylaminoethyl 2,2-diphenylvalerate HCL (SKF 525-A) on trimethadione metabolism in the rat.
    Tanaka E; Misawa S; Kuroiwa Y
    J Pharmacobiodyn; 1985 Sep; 8(9):767-72. PubMed ID: 4087136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.
    Stitzel RE; Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):335-40. PubMed ID: 5968073
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of drug metabolism. I. Kinetics of the inhibition of the N-demethylation of ethylmorphine by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and related compounds.
    Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):319-27. PubMed ID: 5968071
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of co-administration of monomethylaminoantipyrine with diethylaminoethyl 2,2-diphenylvalerate (SKF 525-A) on gamma-glutamyltranspeptidase, glutathione S-transferase and hepatic drug metabolizing enzyme activities in rats.
    Hoshi K; Senda N; Igarashi T; Satoh T; Ueno K; Kitagawa H
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):71-80. PubMed ID: 2872706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of steroid-mediated induction of delta-aminolevulinic acid synthase by 2-diethylaminoethyl-2,2-diphenylvalerate HCl (SKF 525-A).
    Lane SE; Gidari AS; Levere RD
    Biochim Biophys Acta; 1982 May; 716(2):117-25. PubMed ID: 7093306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma enzyme activity induced by 2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride (SKF 525-A).
    Koff RS; Fitts JJ
    Biochem Pharmacol; 1972 Apr; 21(7):1053-5. PubMed ID: 5039749
    [No Abstract]   [Full Text] [Related]  

  • 8. 2-Diethylaminoethyl-2,2-diphenylvalerate-HCl (SKF525A) revisited: comparative cytochrome P450 inhibition in human liver microsomes by SKF525A, its metabolites, and SKF-acid and SKF-alcohol.
    Franklin MR; Hathaway LB
    Drug Metab Dispos; 2008 Dec; 36(12):2539-46. PubMed ID: 18799803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 5,5'-diphenylhydantoin on the metabolism of L-thyroxine-131-I in the rat.
    Mendoza DM; Flock EV; Owen CA; Paris J
    Endocrinology; 1966 Jul; 79(1):106-18. PubMed ID: 4161992
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitory effect of 2-diethylaminoethyl 2,2-diphenylvalerate hydrochloride (SKF 525-A) on aromatic hydroxylation and phenolic glucuronidation.
    Ikeda M; Tanaka S; Katayama T
    Mol Pharmacol; 1968 Jan; 4(1):38-43. PubMed ID: 5640778
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of drug metabolism. IV. Induction of drug metabolism by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and 2,4-dichloro-6-phenylphenoxyethylamine HBr (Lilly 18947) and the effect of induction on the inhibitory properties of SKF 525-A type compounds.
    Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):341-6. PubMed ID: 5968074
    [No Abstract]   [Full Text] [Related]  

  • 12. The inhibitory effect of diethylaminoethyl diphenylvalerate (SKF 525-A) on glucuronidation by cultures of rat hepatoma cells.
    Dybing E; Rugstad HE
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):112-8. PubMed ID: 4354657
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of drug metabolism. II. Metabolism of 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A).
    Anders MW; Alvares AP; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):328-34. PubMed ID: 5968072
    [No Abstract]   [Full Text] [Related]  

  • 14. The delay of the behavioral effects of 9 -tetrahydrocannabinol in rats by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A).
    Peterson DW; Cohen GM; Sparber SB
    Life Sci I; 1971 Dec; 10(24):1381-6. PubMed ID: 5146321
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of 2-diethylaminoethyl-2,2-diphenylvalerate hydrochloride (SKF 525-A) on sulphacetamide distribution and excretion in rats.
    Marchand C; Nadeau D
    Br J Pharmacol; 1973 Jan; 47(1):69-76. PubMed ID: 4717021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of chlorpromazine and diethylaminoethyl diphenylvalerate (SKF 525-A) on alanine incorporation into protein and -aminoisobutyric acid uptake in rat hepatoma cells in culture.
    Dybing E
    Biochem Pharmacol; 1973 Mar; 22(5):591-600. PubMed ID: 4348115
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure-activity relationships of inhibition of hepatic monodeiodination of thyroxine to 3,5,3'-triiodothyronine by thiouracil and related compounds.
    Chopra IJ; Chua Teco GN; Eisenberg JB; Wiersinga WM; Solomon DH
    Endocrinology; 1982 Jan; 110(1):163-8. PubMed ID: 7053981
    [No Abstract]   [Full Text] [Related]  

  • 18. The local anesthetic activity of proadifen HCl (2-diethylaminoethyl-alpha,alpha-diphenylvalerate, HCl).
    Guerrero S; Montoya G; Molgó J
    Eur J Pharmacol; 1970 Apr; 10(1):131-4. PubMed ID: 5458979
    [No Abstract]   [Full Text] [Related]  

  • 19. SKF 525A displaces drugs from serum alpha 1-acid glycoprotein binding sites.
    Belpaire FM; Chindavijak B; Bogaert MG
    J Pharmacol Exp Ther; 1987 Feb; 240(2):628-30. PubMed ID: 3806415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of SKF-525-A on the metabolism of (minus)-delta9-tetrahydrocannabinol in the rat brain and liver.
    Estevez VS; Englert LF; Ho BT
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):389-92. PubMed ID: 4851722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.